Edition:
United Kingdom

Vericel Corp (VCEL.OQ)

VCEL.OQ on NASDAQ Stock Exchange Capital Market

16.04USD
14 Jun 2019
Change (% chg)

$-0.49 (-2.96%)
Prev Close
$16.53
Open
$16.50
Day's High
$16.65
Day's Low
$16.02
Volume
132,713
Avg. Vol
186,202
52-wk High
$21.00
52-wk Low
$8.98

Latest Key Developments (Source: Significant Developments)

Vericel Q1 Loss Per Share $0.07
Tuesday, 7 May 2019 

Vericel Corp ::VERICEL REPORTS FIRST QUARTER 2019 FINANCIAL RESULTS AND RAISES FULL YEAR 2019 REVENUE GUIDANCE.Q1 LOSS PER SHARE $0.07.Q1 EARNINGS PER SHARE ESTIMATE $-0.07 -- REFINITIV IBES DATA.QTRLY TOTAL NET PRODUCT REVENUES INCREASED 21% TO $21.8 MILLION COMPARED TO $18.0 MILLION IN Q1 OF 2018.QTRLY GROSS MARGINS OF 60% COMPARED TO GROSS MARGINS OF 57% IN Q1 OF 2018.NOW EXPECTS TOTAL MACI AND EPICEL NET PRODUCT REVENUES FOR FULL YEAR 2019 TO BE IN RANGE OF $110 TO $114 MILLION.Q1 REVENUE VIEW $22.5 MILLION -- REFINITIV IBES DATA.  Full Article

Vericel Reports Q1 Loss Per Share Of $0.21
Tuesday, 8 May 2018 

May 8 (Reuters) - Vericel Corp ::VERICEL REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS.Q1 LOSS PER SHARE $0.21.Q1 REVENUE $18 MILLION VERSUS I/B/E/S VIEW $16.8 MILLION.Q1 EARNINGS PER SHARE VIEW $-0.13 -- THOMSON REUTERS I/B/E/S.AS OF MARCH 31, 2018, COMPANY HAD $29.8 MILLION IN CASH COMPARED TO $26.9 MILLION IN CASH AT DECEMBER 31, 2017.  Full Article

Vericel Q4 Revenue Rose 41 Pct To $23.4 Mln
Monday, 5 Mar 2018 

March 5 (Reuters) - Vericel Corp ::VERICEL REPORTS FOURTH QUARTER AND YEAR END 2017 FINANCIAL RESULTS AND PROVIDES FULL YEAR 2018 FINANCIAL GUIDANCE.Q4 EARNINGS PER SHARE $0.01.Q4 REVENUE ROSE 41 PERCENT TO $23.4 MILLION.EXPECTS TOTAL NET PRODUCT REVENUES FOR FULL YEAR 2018, EXCLUDING ADDITIONAL LICENSE REVENUE, TO BE IN RANGE OF $73 MILLION TO $78 MILLION.  Full Article

Vericel Initiates Collaboration with Innovative Cellular Therapeutics
Tuesday, 2 Jan 2018 

Jan 2 (Reuters) - Vericel Corp ::VERICEL CORP - ‍INITIATION OF LICENSE AGREEMENT WITH INNOVATIVE CELLULAR THERAPEUTICS FOLLOWING RECEIPT OF $5.1 MILLION UPFRONT,WARRANT PAYMENT FROM ICT​.VERICEL - ‍UNDER DEAL,ICT WILL DEVELOP,DISTRIBUTE MACI EPICE,IXMYELOCEL-T,CARTICEL IN GREATER CHINA,SOUTH KOREA, SINGAPORE, OTHER COUNTRIES IN REGION​.  Full Article

Vericel Enters Into Expanded $25 Million Debt Facilities With Silicon Valley Bank And Midcap Financial
Thursday, 7 Dec 2017 

Dec 7 (Reuters) - Vericel Corp ::VERICEL ENTERS INTO EXPANDED $25 MILLION DEBT FACILITIES WITH SILICON VALLEY BANK AND MIDCAP FINANCIAL TO SUPPORT ACCELERATING MACI UPTAKE AND INCREASED EPICEL USAGE.VERICEL-ENTERED INTO EXPANDED $15 MILLION TERM LOAN, RETAINED EXISTING $10 MILLION REVOLVING LINE OF CREDIT WITH SILICON VALLEY BANK,MIDCAP FINANCIAL SERVICES​.  Full Article

Vericel reports Q3 loss per share $0.16
Tuesday, 7 Nov 2017 

Nov 7 (Reuters) - Vericel Corp :Vericel reports third-quarter 2017 financial results.Q3 loss per share $0.16.Q3 revenue $14.3 million versus I/B/E/S view $13.9 million.Q3 earnings per share view $-0.16 -- Thomson Reuters I/B/E/S.Vericel Corp - ‍As of September 30, 2017, company had $15.5 million in cash compared to $23.0 million in cash at December 31, 2016​.  Full Article

Vericel Q2 loss per share $0.07
Wednesday, 9 Aug 2017 

Aug 9 (Reuters) - Vericel Corp ::Vericel reports second-quarter 2017 financial results.Q2 loss per share $0.07.Q2 revenue rose 32 percent to $17 million.Q2 revenue view $12.9 million -- Thomson Reuters I/B/E/S.Q2 earnings per share view $-0.20 -- Thomson Reuters I/B/E/S.  Full Article